Asthma Therapeutics Market Opportunities, Size, and Competitive Analysis till 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Asthma Therapeutics Market covers analysis By Product Type (Dry powder inhalers, Metered dose inhalers, Mist inhalers, Nebulizer); Drug Class (Anti-inflammatory drugs, Bronchodilators, Combination therapy); Route of administration (Oral, Inhaled, Intravenous, Subcutaneous) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00004065
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Asthma Therapeutics Market is expected to register a CAGR of 5.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Asthma Therapeutics Market report covers analysis by Product Type (Dry powder inhalers, Metered dose inhalers, Mist inhalers, Nebulizer); Drug Class (Anti-inflammatory drugs, Bronchodilators, Combination therapy); Route of administration (Oral, Inhaled, Intravenous, Subcutaneous), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Asthma Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Asthma Therapeutics Market Segmentation

Product Type

  • Dry powder inhalers
  • Metered dose inhalers
  • Mist inhalers
  • Nebulizer

Drug Class

  • Anti-inflammatory drugs
  • Bronchodilators
  • Combination therapy

Route of administration

  • Oral
  • Inhaled
  • Intravenous
  • Subcutaneous

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Asthma Therapeutics Market: Strategic Insights

asthma-therapeutics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asthma Therapeutics Market Growth Drivers

  • Increased incidence of asthma: Asthma is a chronic respiratory condition that is increasingly becoming common worldwide, due to urbanization, increased exposure to allergens, pollution, and lifestyle changes. This increase in asthma cases has created a higher demand for medications and treatments to manage the condition. In January 2023, AstraZeneca's Tezspire (tezepelumab) was adopted by CHMP with a positive opinion for self-administration through a prefilled pen for patients diagnosed with severe asthma aged 12 years and older, increasing convenience and flexibility. As more people are diagnosed with asthma, the need for effective therapeutic solutions continues to grow, driving the expansion of the asthma therapeutics market.
  • Increasing awareness and early diagnosis: Public health campaigns and awareness programs have increased the knowledge of asthma symptoms, including wheezing, shortness of breath, and coughing. Thus, people take medical advice early on and undergo proper diagnosis and treatment. Early interventions can help prevent severe complications and enhance patient quality of life, making patients increase demands for a variety of asthma management options such as medicines and inhalers.
  • Developments in the inhalation equipment: Technological advancements in inhalation devices have made them more efficient and user-friendly. Smart inhalers, for instance, can monitor usage and provide reminders to adhere to treatment regimens. They ensure that the right dose of medication is given to the patient, thereby maximizing the outcome of treatment. In March 2023, Teva Pharmaceuticals collaborated with Rimidi to introduce respiratory patient monitoring with data from the Digihaler System by Teva at Desert Oasis Healthcare in California. The Digihaler is a smart inhaler system that provides objective data for asthma management. Convenience and improved efficacy are the factors that make the modern inhalation device increasingly popular for asthma management.

Asthma Therapeutics Market Future Trends

  • Biologics usage is increasing: Advances in the treatment of severe asthma have been dramatically achieved with the introduction of biologics such as monoclonal antibodies, by targeting specific immune responses that play a role in the disease. These therapies have been especially valuable for patients experiencing frequent exacerbations despite standard therapy. The increasing usage of biologics, which offer substantial enhancements in asthma control and quality of life, is what is driving its adoption in clinical practice and adding to market expansion.
  • Combination therapies: Combination therapies are many medications in a single inhaler and can result in an even more streamlined, adherent patient, which consequently has an improvement in effectiveness overall. Combining LABAs with ICS often targets complementary elements of the therapy in asthma care. Convenience coupled with enhanced effectiveness are reasons behind their increasing acceptance by both practitioners and patients for a prescription.
  • Digital Health Integration: The progress of digital health technologies, including mobile applications and wearable devices, as companions for asthma management, monitoring symptoms, tracking the use of medication, receiving reminders, and enhancing self-management have been significantly improved. For providers, digital health solutions provide valuable data on the assessment of disease control and adaptation in treatment plans. Innovation in care for asthma has been improved with better patient outcomes and engagement as a result of the integration of these technologies.

Asthma Therapeutics Market Opportunities

  • Development of next-generation biologics: The discovery of new biological targets and pathways is opening the door to next-generation biologics. These drugs are designed to be more effective, have fewer side effects, and provide better patient outcomes. In August 2023, Areteia Therapeutics declared results from the Phase 2 EXHALE-1 study, showing the drug was capable of decreasing blood eosinophil count. Also, In July 2022, Areteia Therapeutics secured funding of USD 350 million for developing an oral asthma treatment for patients suffering from eosinophilic asthma. Success in these areas may help expand treatment options for asthma, especially for severe asthma, and open new revenue streams for pharmaceutical companies.
  • Increasing focus on pediatric asthma management: Children with asthma need to be treated differently compared to adults, and hence their care requires more specific handling. There is an increasing trend toward developing pediatric-specific formulations, like reduced doses and child-friendly delivery devices, that can ensure safety and effectiveness. It creates a niche market as managing asthma in children presents specific challenges, opening the scope for companies to develop solutions that help enhance pediatric outcomes of asthma.
  • Increasing Home-based Solutions for Asthma Management: This trend toward home-based care is, therefore, creating demand for such products that will enable patients to take greater control of managing their asthma on their own. Included in this are portable nebulizers, smart inhalers, and digital tools that can track symptoms and promote medicine adherence. These have been favored because they offer greater convenience and allow patients to take more control over their health care, relieving overburdened healthcare systems and promoting patient autonomy.

Asthma Therapeutics Market Regional Insights

The regional trends and factors influencing the Asthma Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Asthma Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

asthma-therapeutics-market-global-geography
  • Get the Regional Specific Data for Asthma Therapeutics Market

Asthma Therapeutics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 5.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product Type
  • Dry powder inhalers
  • Metered dose inhalers
  • Mist inhalers
  • Nebulizer
By Drug Class
  • Anti-inflammatory drugs
  • Bronchodilators
  • Combination therapy
By Route of administration
  • Oral
  • Inhaled
  • Intravenous
  • Subcutaneous
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AstraZeneca
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • Cipla Inc
  • Intas Pharmaceuticals Ltd
  • Merck Sharp and Dohme Corp
  • F. Hoffmann-La Roche Ltd

  • Asthma Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

    The Asthma Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Asthma Therapeutics Market are:

    1. AstraZeneca
    2. GlaxoSmithKline Plc.
    3. Teva Pharmaceutical Industries Ltd.
    4. Boehringer Ingelheim International GmbH
    5. Sanofi
    6. Cipla Inc

    Disclaimer: The companies listed above are not ranked in any particular order.


    asthma-therapeutics-market-cagr

    • Get the Asthma Therapeutics Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Asthma Therapeutics Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Asthma Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What are the major driving factors impacting the Asthma Therapeutics Market?

    The major factors driving the Asthma Therapeutics Market are Increased incidence of asthma, Increasing awareness and early diagnosis, and Developments in the inhalation equipment

    What are the future trends of the Asthma Therapeutics Market?

    The key future trends of the market are Biologics usage is increasing, Combination therapies, and Digital Health Integration

    Which are the leading players operating in the Asthma Therapeutics Market?

    The leading players operating in the Asthma Therapeutics Market include AstraZeneca, GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sanofi, Cipla Inc, Intas Pharmaceuticals Ltd, Merck Sharp and Dohme Corp, F. Hoffmann-La Roche Ltd.

    What are the deliverable formats of Asthma Therapeutics Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report?

    Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    - AstraZeneca
    - GlaxoSmithKline Plc.
    - Teva Pharmaceutical Industries Ltd.
    - Boehringer Ingelheim International GmbH
    - Sanofi
    - Cipla Inc
    - Intas Pharmaceuticals Ltd
    - Merck Sharp and Dohme Corp
    - F. Hoffmann-La Roche Ltd
    - Dr Reddy's Laboratories Ltd
    - Sunovion Pharmaceuticals, Inc
    - Abbott
    - Glenmark
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo